Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay

ABSTRACT The Abbott ID NOW COVID-19 assay is a rapid point-of-care molecular test for SARS-CoV-2 detection. In theory, it has the potential to decrease turnaround times (TATs) and rapidly facilitate patient flow and triage. Reports for its performance have been mixed, likely due to variations in pat...

Full description

Bibliographic Details
Main Authors: K. R. Barker, L. N. Small, D. V. Thai, K. Y. Sohn, L. C. Rosella
Format: Article
Language:English
Published: American Society for Microbiology 2022-06-01
Series:Microbiology Spectrum
Subjects:
COVID-19
SARS-CoV-2
rapid testing
ID NOW
POCT
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00513-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.00513-22

Similar Items